CStone Pharmaceuticals
Dan Li has held various roles throughout their work experience. They started in 2009 as an Associate Scientist at GSK and then moved on to become a Senior Analyst at AmerisourceBergen in 2015. In 2017, they became a BD Manager at CStone. They then worked as the Director of Business Development at Foundation Medicine starting in 2020. Currently, they hold the position of General Manager at Anlogic Graphics.
Dan Li received a Bachelor's degree in Biotechnology from China Pharmaceutical University in 2006. Subsequently, from 2006 to 2009, they pursued a Master of Science (MS) degree in Biotechnology at the KTH Royal Institute of Technology.
This person is not in any teams
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.